1. Aspirin is used in the treatment and prevention of myocardial infar

1. Aspirin is used in the treatment and prevention of myocardial infarction. Justify? 2. Athletes have bradycardia. Explain? 3. Explain why Cardiac muscle does not undergo tetanisation 4. Explain how vagal stimulation decreases the heart rate 5. Heart rate above 180 beats/min decreases the Cardiac output. Why? 6. Why do individuals faint on prolonged standing? 7. Why is there Pedal edema in Right heart failure? By gk pal

Reading File

Finding Sources

Reading File

Finding Sources

Reading File

Finding Sources

I now have enough information from authoritative textbooks (Ganong's Physiology, Katzung's Pharmacology, Braunwald's Heart Disease) to give a comprehensive answer to all 7 questions. Let me compile the full response now.

Here are detailed answers to all 7 questions, based on GK Pal's physiology framework, supported by Ganong's Review of Medical Physiology, Katzung's Basic and Clinical Pharmacology, and Braunwald's Heart Disease.

1. Aspirin in Treatment and Prevention of Myocardial Infarction

Mechanism - Inhibition of Thromboxane A2:

Myocardial infarction (MI) is primarily caused by thrombus formation at the site of a ruptured atherosclerotic plaque. Platelet aggregation is the key step in this process, and it is largely driven by thromboxane A2 (TXA2).

Platelets synthesize TXA2 from arachidonic acid via the enzyme cyclooxygenase-1 (COX-1)
TXA2 causes platelets to change shape, release granules, and aggregate - amplifying clot formation
TXA2 also causes vasoconstriction, worsening ischemia

How aspirin works:

Aspirin irreversibly acetylates COX-1, permanently blocking TXA2 synthesis. Since platelets lack nuclei and cannot synthesize new COX, this inhibition lasts the entire lifespan of the platelet (~7-10 days). Even low doses (75-100 mg/day) achieve near-complete inhibition of TXA2.

Why low dose? At low doses, aspirin inhibits platelet TXA2 synthesis while relatively sparing vascular endothelial production of prostacyclin (PGI2) - a vasodilator and platelet aggregation inhibitor. At high doses, PGI2 is also suppressed, which would reduce the antiplatelet benefit.

Clinical evidence: Aspirin produces about a 20% reduction in the risk of cardiovascular death, MI, or stroke in high-risk patients. Meta-analyses confirm its utility in secondary prevention (patients with prior vascular events). Primary prevention use (no prior event) requires more careful risk-benefit analysis given bleeding risk.

Katzung's Basic and Clinical Pharmacology, 16th Ed.
Braunwald's Heart Disease, p. [block 14]

2. Athletes Have Bradycardia - Explanation

Physiological (Sinus) Bradycardia - Heart rate < 60 beats/min:

Well-conditioned athletes frequently have resting heart rates of 40-60 beats/min, sometimes below 40 beats/min. This is a normal physiological adaptation to sustained aerobic training, not a pathological state.

Mechanism:

Increased stroke volume: Regular endurance training causes cardiac hypertrophy (eccentric) and increased ventricular chamber volume. With each beat, the heart ejects a larger stroke volume. Since Cardiac Output = Heart Rate × Stroke Volume, the same resting cardiac output can be maintained at a lower heart rate.
Increased vagal (parasympathetic) tone: Training causes a sustained increase in resting parasympathetic tone to the sinoatrial (SA) node. Vagal stimulation slows the rate of phase 4 diastolic depolarization in pacemaker cells, reducing the heart rate. This is the dominant mechanism.
Decreased sympathetic tone: Athletes have lower resting sympathetic activity, contributing further to the slower resting rate.
Intrinsic changes in the SA node: Reduced intrinsic automaticity due to adaptations in the funny current (If) and calcium channels in pacemaker cells.

Clinical note: This bradycardia is benign and often associated with sinus arrhythmia, first-degree AV block, and Wenckebach (Mobitz I) block - all due to the same elevated vagal tone. It does not require treatment.

Textbook of Family Medicine, 9th Ed.; Harrison's Principles of Internal Medicine, 22nd Ed.

3. Cardiac Muscle Does Not Undergo Tetanisation

Why skeletal muscle can tetanize but cardiac muscle cannot:

Tetanisation occurs in skeletal muscle when repeated stimuli arrive before the muscle has fully relaxed - summation of contractions occurs until a sustained maximal contraction (tetanus) results. This requires the stimulus interval to be shorter than the contraction duration.

The key difference - Prolonged Action Potential and Refractory Period:

Property	Skeletal Muscle	Cardiac Muscle
Action potential duration	~1-2 ms	~200-300 ms
Absolute refractory period	~1-2 ms	~200 ms (coincides with contraction)
Can summate?	Yes	No

In cardiac muscle:

Phases 0-2 and much of phase 3 (until membrane potential reaches approximately -50 mV during repolarization) constitute the absolute refractory period
This period lasts nearly as long as the mechanical contraction itself
Therefore, a second stimulus CANNOT excite the muscle while it is still contracting - no summation is possible

Why is this physiologically protective?

Tetanization of cardiac muscle would mean sustained contraction with no relaxation - the ventricles would never empty, resulting in zero cardiac output and immediate death. The prolonged refractory period is thus a life-saving design feature that ensures rhythmic, alternating contraction and relaxation.

"During phases 0 to 2 and about half of phase 3 (until the membrane potential reaches approximately -50 mV during repolarization), cardiac muscle cannot be excited again; that is, it is in its absolute refractory period. It remains relatively refractory until phase 4. Therefore, tetanus of the type seen in skeletal muscle cannot occur. Of course, tetanization of cardiac muscle for any length of time would have lethal consequences."

Ganong's Review of Medical Physiology, 26th Ed.

4. Vagal Stimulation Decreases Heart Rate - Mechanism

Vagal (parasympathetic) stimulation releases acetylcholine (ACh) at the SA node, which acts on M2 muscarinic receptors. This produces three main ionic effects:

1. Increased K+ conductance (IK(ACh)):

M2 receptor activation (via Gi protein → βγ subunits) opens GIRK channels (G-protein-coupled inward rectifier K+ channels)
K+ efflux hyperpolarizes the cell (resting membrane potential becomes more negative, e.g., from -60 to -75 mV)
This takes the membrane potential further away from threshold, making it harder to fire

2. Decreased Ca2+ current (ICa):

M2 receptor activation (via Gi → reduced cAMP → reduced PKA) decreases the slow inward L-type Ca2+ current
This reduces the rate and slope of phase 4 diastolic depolarization

3. Decreased funny current (If):

The hyperpolarization-activated "funny" current (If), which drives spontaneous diastolic depolarization in pacemaker cells, is reduced
This directly slows the rate at which the pacemaker potential drifts toward threshold

Net result: All three effects slow the rate of spontaneous phase 4 depolarization in SA node cells, so it takes longer to reach threshold - resulting in a lower heart rate (negative chronotropy). Stronger vagal stimulation can also slow AV conduction (increased PR interval) or even produce transient AV block.

Katzung's Basic and Clinical Pharmacology, 16th Ed., Ch. 7

5. Heart Rate > 180 beats/min Decreases Cardiac Output

Cardiac Output (CO) = Heart Rate (HR) × Stroke Volume (SV)

At moderate increases in HR, CO rises because the increase in rate more than compensates for any reduction in filling. However, above ~180 beats/min, CO paradoxically falls. The reason is critically reduced diastolic filling time.

Why diastolic filling time is critical:

The cardiac cycle has two phases: systole (contraction) and diastole (relaxation and filling)
At rest (~70 bpm), diastole lasts ~500 ms - ample time for ventricular filling
As HR rises, both systole and diastole shorten, but diastole shortens disproportionately
At 180+ bpm, diastolic filling time may be as short as ~100 ms
Ventricular filling is critically reduced, leading to a very small end-diastolic volume (EDV)

Frank-Starling consequence:

By the Frank-Starling mechanism, a smaller EDV means less ventricular stretch at end-diastole, which means weaker contraction and a smaller stroke volume. The stroke volume falls so much that the overall CO decreases despite the high rate.

Additional factors at very high rates:

Reduced time for coronary perfusion (which occurs mainly during diastole) → subendocardial ischemia → reduced myocardial contractility
Possible impaired Ca2+ cycling and diastolic dysfunction

Tachycardia also increases diastolic filling pressure (as less filling time means incomplete emptying and elevated residual pressure), contributing to pulmonary congestion - relevant in conditions like mitral stenosis.

6. Individuals Faint on Prolonged Standing (Orthostatic Syncope)

Normal physiology on standing:

When a person stands up, gravity causes 500-800 mL of blood to pool in the veins of the lower limbs and splanchnic circulation. Normally, baroreceptor reflexes (increased sympathetic tone, reduced vagal tone) compensate rapidly by:

Increasing HR
Causing vasoconstriction
Maintaining venous return and cardiac output

Why fainting occurs with prolonged standing:

Venous pooling: Continued standing causes progressive pooling of blood in the lower extremity venous capacitance vessels. The calf muscle pump (which normally helps return blood) is inactive during quiet standing.
Decreased venous return: As 0.5-1 litre of blood shifts downward, venous return (preload) falls significantly.
Decreased stroke volume and cardiac output: By the Frank-Starling mechanism, reduced preload → reduced stroke volume → reduced CO → reduced arterial pressure.
Cerebral hypoperfusion: When cerebral perfusion pressure falls below the autoregulatory threshold (~50-60 mmHg mean arterial pressure), cerebral blood flow decreases, causing loss of consciousness (syncope).
Why compensation fails in prolonged standing: The initial sympathetic response may be inadequate (neurally mediated/vasovagal mechanism) or the degree of pooling simply overwhelms compensatory capacity. Hot environments, dehydration, prolonged immobility, and venous insufficiency exacerbate pooling.

Vasovagal component: In some individuals, the vigorous cardiac contractions against a near-empty ventricle activate C-fibre mechanoreceptors (Bezold-Jarisch reflex), paradoxically triggering a sudden surge of vagal activity and sympathetic withdrawal - causing bradycardia + vasodilatation = sudden drop in BP and syncope.

Braunwald's Heart Disease - Orthostatic Blood Pressure section

7. Pedal Edema in Right Heart Failure

Mechanism - Starling's Hypothesis of Capillary Fluid Exchange:

Edema forms when fluid moves out of capillaries into the interstitium faster than lymphatics can drain it. This depends on the balance of Starling forces:

Net filtration = Kf × [(Pc - Pi) - σ(πc - πi)]

Pc = capillary hydrostatic pressure
πc = plasma oncotic pressure
Pi = interstitial hydrostatic pressure
πi = interstitial oncotic pressure

How Right Heart Failure Causes Pedal Edema:

Right ventricular failure → decreased forward output → blood backs up into the right atrium → elevated right atrial pressure
Elevated systemic venous pressure: The backed-up pressure propagates retrogradely into the systemic venous circulation → increased venous hydrostatic pressure throughout
Increased capillary hydrostatic pressure (Pc) in dependent areas: In the feet and ankles (the most gravity-dependent regions), the elevated venous back-pressure markedly raises capillary hydrostatic pressure
Net outward filtration exceeds lymphatic return: The elevated Pc drives fluid out of capillaries into the interstitial space of the feet and ankles faster than lymphatics can drain it → pitting edema forms

Why it is pedal (dependent) edema:

Gravity adds hydrostatic pressure to the already elevated venous pressure specifically in the feet and ankles
In a supine patient, this becomes sacral edema instead
The low oncotic pressure from hepatic congestion (reduced albumin synthesis) in chronic right heart failure may worsen edema further

Why not pulmonary edema? Right heart failure raises systemic venous pressure, not pulmonary venous pressure. Pulmonary edema occurs in left heart failure when pulmonary venous/capillary pressure rises.

Braunwald's Heart Disease, block 1 (clinical features); Tintinalli's Emergency Medicine

Summary Table

#	Question	Core Mechanism
1	Aspirin in MI	Irreversible COX-1 inhibition → blocks TXA2 → antiplatelet
2	Athlete bradycardia	Increased vagal tone + increased stroke volume from training
3	No tetanisation	Prolonged absolute refractory period coincides with contraction
4	Vagal slows HR	ACh → M2 → ↑IK(ACh), ↓ICa, ↓If → slowed pacemaker depolarization
5	HR >180 ↓ CO	Critical reduction in diastolic filling time → ↓EDV → ↓SV > ↑HR
6	Fainting on standing	Venous pooling → ↓venous return → ↓CO → cerebral hypoperfusion
7	Pedal edema in RHF	RV failure → ↑systemic venous pressure → ↑capillary Pc in legs

This is a shared conversation. Sign in to Orris to start your own chat.